Insulin Delivery Devices Market
Insulin Delivery Devices Market Size, Share & Trends Analysis Report by Type (Insulin Syringes, Insulin Pens, Insulin Jet Injectors, and Insulin Pumps), and by End-User (Hospitals & Clinics, and Homecare), Forecast Period (2026-2035)
Industry Overview
Insulin delivery devices market was valued at $16.2 billion in 2025 and is projected to reach $33.3 billion by 2035, growing at a CAGR of 7.5% during the forecast period (2026-2035). The market is expanding primarily due to the increasing prevalence of diabetes across all age groups, which has heightened demand for reliable and user-friendly insulin administration methods. Rising awareness of home-based diabetes management and self-administration practices has further fueled the adoption of insulin pens, pumps, and syringes. Technological advancements in device design, including smart pumps and connected pen systems, have improved dosing accuracy and patient adherence, strengthening market growth. Additionally, supportive healthcare initiatives and reimbursement policies in key regions are facilitating broader accessibility of these devices.
Market Dynamics
Rising Adoption of Smart and Connected Insulin Delivery Systems
The market is witnessing significant momentum from the growing adoption of smart insulin delivery devices that integrate with digital health platforms. Connected insulin pens and pumps enable real-time glucose monitoring, dose tracking, and automated alerts, enhancing treatment accuracy and patient adherence. These systems reduce the risk of dosing errors and support personalized therapy, which is increasingly valued by healthcare providers and patients. Integration with mobile applications and cloud-based platforms also facilitates remote monitoring by clinicians. Consequently, this trend is encouraging the replacement of conventional devices with technologically advanced solutions, driving market expansion.
Increasing Focus on Home-Based Diabetes Management
Homecare settings are becoming a critical driver for insulin delivery device demand, as patients prefer self-administration over frequent hospital visits. Rising awareness of the benefits of early intervention and continuous glucose management is promoting the adoption of user-friendly pens, pumps, and jet injectors. Healthcare systems are supporting this shift through education programs, remote monitoring tools, and reimbursement policies for home-use devices. Convenience, ease of use, and safety features tailored for home environments are further encouraging patient preference for self-management. This trend is expanding the market beyond clinical settings and strengthening long-term growth prospects.
Market Segmentation
- Based on the type, the market is segmented into insulin syringes, insulin pens, insulin jet injectors, and insulin pumps.
- Based on the end-user, the market is segmented into hospitals & clinics, and home care.
Insulin Pens Driving Homecare Convenience and Accuracy
Insulin pens are a leading sub-segment under the type category, experiencing strong growth due to their ease of use, portability, and precise dosing capabilities. Increasing preference for self-administration in home care settings has reinforced their adoption, as patients seek more convenient and less invasive options than traditional syringes. Technological enhancements, including prefilled pens and memory-enabled devices, have improved adherence and safety, particularly for elderly and insulin-dependent patients. Manufacturers are also introducing smart pens that integrate with digital health platforms, aligning with broader market trends in connected healthcare. Consequently, insulin pens are emerging as a key growth driver within both hospital and homecare end-use segments.
Homecare Segment Expanding Through Patient-Centric Diabetes Management
The home care sub-segment under End-User is witnessing accelerated growth as patients increasingly manage diabetes outside clinical settings. Rising awareness of self-management benefits, coupled with supportive reimbursement policies for home-use devices, is driving demand for user-friendly syringes, pens, and pumps. Remote monitoring solutions and educational programs are enabling patients to adhere to prescribed regimens with greater confidence and safety. The convenience and flexibility of home care administration are reducing dependence on hospitals for routine insulin delivery. This shift is reinforcing the market’s long-term expansion by broadening device utilization beyond institutional settings.
Regional Outlook
The global insulin delivery devices market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Leading the Global Insulin Delivery Devices Market
North America remains the largest regional market, driven by high diabetes prevalence, advanced healthcare infrastructure, and widespread adoption of insulin pens and pumps. Supportive reimbursement policies and strong awareness of home-based diabetes management are further reinforcing device penetration. Key players such as Medtronic Plc, Abbott Laboratories, and Eli Lilly and Company maintain a dominant presence, introducing innovations like smart insulin pens and connected pump systems. Recent collaborations and acquisitions in the region are also enhancing technology adoption and patient accessibility. The combination of established healthcare networks and technological advancement solidifies North America’s leading position in the market.
Asia-Pacific Emerging as the Fastest-Growing Market
Asia-Pacific is the fastest-growing region, fueled by rising diabetes incidence, increasing healthcare expenditure, and growing awareness of self-administration devices in both urban and semi-urban populations. Expanding home care infrastructure and government initiatives to improve diabetes management are accelerating the adoption of insulin pens, syringes, and pumps. Countries such as China, India, and Japan are witnessing active participation from global and regional players, including Sanofi, Ypsomed Holding AG, and Biocon Ltd. Technological adoption is supported by increasing smartphone penetration and digital health integration.
Market Players Outlook
The major companies operating in the global Insulin Delivery Devices market include Abbott Laboratories, Becton, Dickinson and Company, Eli Lilly and Company, Medtronic Plc, and Sanofi, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In December 2025, Insulet Corporation announced FDA 510(k) clearance for major enhancements to its Omnipod 5 Automated Insulin Delivery System. Key updates include a new 100 mg/dL Target Glucose setting for tighter glucose control and an improved algorithm that helps users stay in Automated Mode longer. These features, highly requested by users and healthcare providers, aim to simplify the Pod experience, offer more personalized diabetes management, and improve clinical outcomes.
- In March 2025, Tandem Diabetes Care launched Control-IQ+, an advanced automated insulin delivery technology in the US. It supports people with type 1 diabetes aged 2+ and adults with type 2 diabetes. Compatible with the t:slim X2 pump and Tandem Mobi System, the updated software is available via free remote update for eligible users and pre-loaded on new pumps.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global insulin delivery devices market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Insulin Delivery Devices Market Sales Analysis – Type | End-Use ($ Million)
- Insulin Delivery Devices Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Insulin Delivery Devices Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Insulin Delivery Devices Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Insulin Delivery Devices Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Insulin Delivery Devices Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Insulin Delivery Devices Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Insulin Delivery Devices Market Revenue and Share by Manufacturers
- Insulin Delivery Devices Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Becton, Dickinson and Company
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Eli Lilly and Company
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic Plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Sanofi
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories
- Key Company Analysis
- Global Insulin Delivery Devices Market Sales Analysis by Type ($ Million)
- Insulin Syringes
- Insulin Pens
- Insulin Jet Injectors
- Insulin Pumps
- Global Insulin Delivery Devices Market Sales Analysis by End-User ($ Million)
- Hospitals & Clinics
- Homecare
- Regional Analysis
- North American Insulin Delivery Devices Market Sales Analysis – Type | End-User | Country ($ Million)
- United States
- Canada
- North American Insulin Delivery Devices Market Sales Analysis – Type | End-User | Country ($ Million)
- European Insulin Delivery Devices Market Sales Analysis – Type | End-User | Country ($ Million)
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Insulin Delivery Devices Market Sales Analysis – Type | End-User | Country ($ Million)
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Insulin Delivery Devices Market Sales Analysis – Type | End-User | Country ($ Million)
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Becton, Dickinson and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biocon Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CeQur Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medical Industries Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- EOFLOW Co., Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- European Pharma Group BV
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann?La Roche Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hindustan Syringes & Medical Devices Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HTL?STREFA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Insulet Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic Plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nemera
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ocean (Hangzhou) Medical Technology Co Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Owen Mumford Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SHL Medical
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SOOIL Developments Co., Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SUNGSHIM MEDICAL Co., Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Tandem Diabetes Care, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ypsomed Holding AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Embecta Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global Insulin Delivery Devices Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global Insulin Syringes Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Insulin Pens Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Insulin Jet Injectors Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Insulin Pumps Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Insulin Delivery Devices Market Research and Analysis by End-User, 2025–2035 ($ Million)
7. Global Insulin Delivery Devices For Hospitals & Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Insulin Delivery Devices For Homecare Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Insulin Delivery Devices Market Research and Analysis by Region, 2025–2035 ($ Million)
10. North American Insulin Delivery Devices Market Research and Analysis by Country, 2025–2035 ($ Million)
11. North American Insulin Delivery Devices Market Research and Analysis by Type, 2025–2035 ($ Million)
12. North American Insulin Delivery Devices Market Research and Analysis by End-User, 2025–2035 ($ Million)
13. European Insulin Delivery Devices Market Research and Analysis by Country, 2025–2035 ($ Million)
14. European Insulin Delivery Devices Market Research and Analysis by Type, 2025–2035 ($ Million)
15. European Insulin Delivery Devices Market Research and Analysis by End-User, 2025–2035 ($ Million)
16. Asia-Pacific Insulin Delivery Devices Market Research and Analysis by Country, 2025–2035 ($ Million)
17. Asia-Pacific Insulin Delivery Devices Market Research and Analysis by Type, 2025–2035 ($ Million)
18. Asia-Pacific Insulin Delivery Devices Market Research and Analysis by End-User, 2025–2035 ($ Million)
19. Rest of the World Insulin Delivery Devices Market Research and Analysis by Region, 2025–2035 ($ Million)
20. Rest of the World Insulin Delivery Devices Market Research and Analysis by Type, 2025–2035 ($ Million)
21. Rest of the World Insulin Delivery Devices Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Insulin Delivery Devices Market Share by Type, 2025 vs 2035 (%)
2. Global Insulin Syringes Market Share by Region, 2025 vs 2035 (%)
3. Global Insulin Pens Market Share by Region, 2025 vs 2035 (%)
4. Global Insulin Jet Injectors Market Share by Region, 2025 vs 2035 (%)
5. Global Insulin Pumps Market Share by Region, 2025 vs 2035 (%)
6. Global Insulin Delivery Devices Market Share by End-User, 2025 vs 2035 (%)
7. Global Insulin Delivery Devices For Hospitals & Clinics Market Share by Region, 2025 vs 2035 (%)
8. Global Insulin Delivery Devices For Homecare Market Share by Region, 2025 vs 2035 (%)
9. Global Insulin Delivery Devices Market Research and Analysis by Region, 2025–2035 ($ Million)
10. US Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
11. Canada Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
12. UK Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
13. France Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
14. Germany Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
15. Italy Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
16. Spain Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
17. Russia Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
18. Rest of Europe Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
19. India Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
20. China Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
21. Japan Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
22. South Korea Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
23. Australia and New Zealand Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
24. ASEAN Economies Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
25. Rest of Asia-Pacific Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
26. Latin America Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
27. Middle East and Africa Insulin Delivery Devices Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
